U.S. Oil and Gas Stock News

NYSE:DHR
NYSE:DHRLife Sciences

Assessing Danaher (DHR) Valuation After Earnings Beat And Optimistic Analyst Sentiment

Danaher (DHR) shares have reacted to a busy stretch of news, with quarterly results that topped Wall Street revenue forecasts. Adjusted EPS growth has drawn attention despite the stock lagging the broader market over the past year. See our latest analysis for Danaher. At around $219.75, Danaher's recent 1-day and 7-day share price returns of about 1% suggest a modest positive reaction to the earnings beat and board changes. The 1-year total shareholder return of roughly 10% contrasts with...
NYSE:CLVT
NYSE:CLVTProfessional Services

How Debt Redemption And Buybacks Plus AI Launch At Clarivate (CLVT) Has Changed Its Investment Story

In late January 2026, Clarivate Plc fully redeemed the remaining US$100 million of its 4.50% senior secured notes due 2026 using cash on hand, while also repurchasing about 56 million shares for US$225 million over 2025. The company also launched Clarivate Nexus, an AI-powered academic assistant aimed at helping students and researchers access trusted library content and discovery tools, underscoring its push to blend AI with its information services platform. We’ll now examine how...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics Advances IPF Program With TETON-2 And PROLIFIC Milestones

United Therapeutics reported positive TETON-2 study results for inhaled treprostinil in idiopathic pulmonary fibrosis (IPF). The data indicate a potential role for inhaled treprostinil in helping stabilize lung function for IPF patients. The FDA qualified the PROLIFIC Risk Score, a tool designed to identify IPF patients at higher risk of rapid progression and support more targeted clinical trials. United Therapeutics (NasdaqGS:UTHR) is drawing attention as it pairs clinical momentum with a...
NYSE:CUBI
NYSE:CUBIBanks

Assessing Customers Bancorp (CUBI) Valuation After Recent Share Price Pullback And Long Term Gains

Recent trading in Customers Bancorp (CUBI) has drawn attention after a one-month return of about a 7% decline, alongside an 8.6% gain over the past 3 months, prompting fresh questions about valuation and earnings power. See our latest analysis for Customers Bancorp. At a share price of $73.14, Customers Bancorp has seen short term momentum ease, with a 7 day share price return of a 6.6% decline, while the 1 year total shareholder return of 25.9% and 5 year total shareholder return of 172.8%...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Is Mattel (MAT) Pricing Reflect Its Brand Strength After Recent Share Price Weakness

For readers wondering whether Mattel, at around US$21.06, is offering fair value right now or if the market is mispricing the toy maker, this article walks through what the numbers actually say about the stock. The share price is US$21.06 after a 0.6% decline over the last 7 days, a 2.0% decline over 30 days, a 5.1% gain year to date and a 3.6% decline over the past year. These moves give mixed signals when you compare them with its 13.5% and 12.9% annualized returns over 3 and 5...
NYSE:BFAM
NYSE:BFAMConsumer Services

A Look At Bright Horizons (BFAM) Valuation As Investors Await The Next Earnings Report

Investors are watching Bright Horizons Family Solutions (BFAM) ahead of Thursday afternoon’s earnings, after the child care provider exceeded analyst expectations on revenue and adjusted earnings last quarter. The company enters this release with forecasts for slower, but still solid, year-on-year growth. See our latest analysis for Bright Horizons Family Solutions. At a share price of $85.04, Bright Horizons has seen a 17.0% 1 month share price return decline and a 14.4% year to date share...
NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

A Look At Sonos (SONO) Valuation After Earnings Efficiency Boosts Profitability

Sonos (SONO) is back in focus after a quarter where sales held around last year’s level, yet net income and earnings per share were much higher, helped by cost controls and product mix changes. See our latest analysis for Sonos. The earnings beat and recent buyback activity have coincided with a sharp shift in sentiment, with a 19.3% 7 day share price return and a 31.9% 1 year total shareholder return contrasting with weaker 3 and 5 year total shareholder returns. This suggests momentum has...
NasdaqCM:SMX
NasdaqCM:SMXElectronic

SMX (Security Matters) (SMX) Is Up 62.3% After Expanding US$250 Million Equity Line of Credit - What's Changed

SMX (Security Matters) recently amended its equity line of credit, lifting the total capital commitment to US$250 million and extending its financing runway into 2028 to support brand protection, authentication, and track-and-trace initiatives. This enlarged and longer-term funding pool gives SMX more flexibility to run multiple platform deployments simultaneously and pursue longer-horizon enterprise and government projects without compressing implementation timelines. Given the strong 7-day...
NYSE:GFF
NYSE:GFFBuilding

Griffon (GFF) Is Up 12.7% After Unveiling ONCAP JV And Pure‑Play Building Products Pivot

In early February 2026, Griffon Corporation reported first-quarter fiscal 2026 results showing sales of US$649.09 million and net income of US$64.39 million, alongside guidance of US$1.8 billion in full‑year revenue from continuing operations and a regular quarterly dividend of US$0.22 per share. On the same day, Griffon unveiled plans to become a pure‑play North American building products company through a new joint venture with ONCAP for its AMES North America business and a review of...
NYSE:RJF
NYSE:RJFCapital Markets

Should AI-Driven Tax Tools Reshape Investors’ View of Raymond James Financial’s (RJF) Advisor-Centric Model?

Recently, Raymond James Financial was swept up in a sector-wide pullback after fintech firm Altruist launched an AI-powered planning tool that automates tax strategy design and document creation for financial advisers. The reaction highlights how quickly investor sentiment can shift when new technology raises questions about the durability of human-centered wealth-management models and fee structures. We’ll now explore how these AI disruption concerns intersect with Raymond James Financial’s...
NYSE:WD
NYSE:WDDiversified Financial

Walker & Dunlop (WD) Deepens Hospitality Financing Role with Nashville EDITION Deal – What Does It Signal?

Earlier in February 2026, Tidal Real Estate Partners secured US$371.5 million in financing from Madison Realty Capital and KSL Capital Partners for The Nashville EDITION Hotel & Residences, with Walker & Dunlop arranging the capital for the 28-story luxury hotel and residential tower. Around the same time, Walker & Dunlop was also recognized as Fannie Mae’s largest DUS lender for 2025 and a top Freddie Mac Optigo lender, underscoring its scale and influence in multifamily and commercial real...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

Is BioMarin Pharmaceutical (BMRN) Now Trading Below Its Long Term Prospects

If you are wondering whether BioMarin Pharmaceutical's current share price lines up with its underlying worth, this article will walk you through what the numbers say and how to interpret them. The stock closed at US$59.66 most recently, with returns of 3.6% over the last 7 days, 1.2% over 30 days, 0.4% year to date, and a 6.1% decline over 1 year, alongside larger declines of 45.1% over 3 years and 29.8% over 5 years. Recent attention on BioMarin has focused on its rare disease drug...
NYSE:RSG
NYSE:RSGCommercial Services

The Bull Case For Republic Services (RSG) Could Change Following Signs Of Volume Stagnation Amid Strong Margins

In recent months, Republic Services reported softer quarterly results and stagnating unit volumes, despite five-year sales increasing at a compounded annual rate of 10.2% and maintaining an average operating margin of 18.9%. This combination of slowing volumes alongside historically solid revenue growth and profitability has raised fresh questions about competition, market saturation, and the potential need for price or investment shifts. We’ll now examine how concerns about stagnating sales...
NYSE:EFC
NYSE:EFCMortgage REITs

Ellington Financial Preferred Redemption Reshapes Capital Stack And Valuation Outlook

Ellington Financial plans to redeem all outstanding shares of its Series A Preferred Stock at the end of February 2026. Following the redemption, the Series A Preferred Stock will be delisted from the NYSE. The move will retire this layer of preferred capital and end related dividend payments to Series A holders. For common shareholders of NYSE:EFC, this preferred stock redemption sits alongside a share price of $12.85 and a mixed recent return profile. The stock is up 2.0% over the past...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Do Tanbreez Assays Push Critical Metals (CRML) Toward a Multi‑Metal Thesis or Added Complexity?

Critical Metals Corp. recently reported final 2025 assay results from Area B and the Fjord Deposit at its Tanbreez Rare Earths Project in Greenland, confirming extensive near-surface rare earth mineralisation with Total Rare Earth Oxide plus yttrium grades generally between 0.35% and 0.61% and heavy rare earths making up around a quarter of the mix. The program also highlighted consistent by-product levels of metals such as niobium, hafnium and gallium across a 1,750-metre corridor,...
NYSE:FCN
NYSE:FCNProfessional Services

A Look At FTI Consulting (FCN) Valuation After February Senior Leadership Appointments

FTI Consulting (FCN) has been busy reshaping its senior leadership, with a cluster of February appointments across healthcare, chemicals, business transformation and intellectual property. These changes give investors fresh context for thinking about the stock. See our latest analysis for FTI Consulting. At a share price of US$173.36, FTI Consulting has seen a 4.8% 90 day share price return and a 1.8% year to date share price return, while the 1 year total shareholder return of 10.2% decline...
NasdaqGS:ARHS
NasdaqGS:ARHSSpecialty Retail

Assessing Arhaus (ARHS) Valuation After Recent Choppy Share Price Performance

Arhaus stock at a glance Arhaus (ARHS) has attracted investor attention after a mixed stretch, with a 15% gain over the past 3 months contrasting with weaker one year and year to date returns at recent prices near US$10.67. See our latest analysis for Arhaus. Recent trading has been choppy, with a 14.9% 90 day share price return contrasting with weaker year to date share price performance and a 14.8% decline in the 1 year total shareholder return. This suggests that momentum has faded after...
NYSE:IFF
NYSE:IFFChemicals

Is International Flavors & Fragrances (IFF) Pricing Reset Justified After Recent Share Price Rebound?

If you are wondering whether International Flavors & Fragrances is offering fair value right now, you are not alone. A closer look at its valuation can help frame your next move. The stock last closed at US$76.76, with recent returns of 9.1% over 7 days, 11.1% over 30 days, 12.8% year to date, but a 7.8% decline over 1 year, a 13.2% decline over 3 years and a 35.9% decline over 5 years. These mixed returns leave many investors looking to recent company updates and sector news to understand...
NYSE:IONQ
NYSE:IONQTech

IonQ (IONQ) Is Down 8.5% After Doubling Down On Vertically Integrated Quantum Platform Strategy

In recent months, IonQ has reported very large year-over-year revenue growth, pursued multi-billion-dollar acquisitions to build a vertically integrated quantum platform, and faced critical short-seller reports questioning its government-heavy revenue mix and aggressive expansion. Amid this tension between rapid expansion and concerns over cash burn and dilution, IonQ’s attempt to consolidate quantum hardware, networking, sensing, and security into one stack has become a central point of...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

The Bull Case For Cytokinetics (CYTK) Could Change Following MYQORZO Progress And HCM Advocacy Grants

Cytokinetics recently announced recipients of its eighth annual Communications Grant Program, awarding two grants to hypertrophic cardiomyopathy patient advocacy groups to expand education and awareness, alongside confirming that MYQORZO (aficamten) is approved for symptomatic obstructive HCM and under marketing review in the European Union. This combination of regulatory progress for MYQORZO and direct support for HCM community outreach highlights how the company is tying its commercial...
NasdaqGS:FFIN
NasdaqGS:FFINBanks

First Financial Bankshares Leadership Shift And What It Means For Valuation

First Financial Bankshares (NasdaqGS:FFIN) has appointed David Bailey as Chief Executive Officer and President. Long-time leader F. Scott Dueser is transitioning to the role of Executive Chairman after many years in top executive positions. The leadership changes mark a new chapter for the company while keeping both executives in key roles. First Financial Bankshares, a regional banking group, sits in a sector that continues to see pressure around funding costs, loan growth, and regulation...
NasdaqGS:ATAT
NasdaqGS:ATATHospitality

Can Morgan Stanley’s Tourism Endorsement Redefine Atour Lifestyle Holdings’ (ATAT) Competitive Edge in China?

Morgan Stanley recently issued a research report highlighting a strong recovery in China's tourism sector, underpinned by robust domestic demand and supportive government policies, and identified Atour Lifestyle Holdings as one of the key hotel operators positioned to benefit from this trend. This endorsement places Atour at the center of the anticipated expansion in tourism-related consumption, underscoring how its hotel-focused lifestyle brands could capture increased travel spending...
NYSE:J
NYSE:JProfessional Services

Jacobs Solutions (J) Is Up 13.7% After SHIELD Win And Q1 Results Beat – Has The Bull Case Changed?

In early February 2026, Jacobs reported first-quarter 2026 results showing sales of US$3,293.28 million and net income of US$125.51 million, while also securing roles on major U.S. infrastructure and defense programs, including the Missile Defense Agency’s SHIELD contract and the Bolivar Roads Gate coastal protection project. These wins highlight Jacobs’ expanding footprint in high-complexity national security, coastal resilience, and rail mobility projects, reinforcing its position at the...